
Dipeptidyl peptidase-4 inhibitors and osteoporosis
Author(s) -
Wen-Ling Lee,
FaKung Lee,
Peng-Hui Wang
Publication year - 2022
Publication title -
journal of the chinese medical association
Language(s) - English
Resource type - Journals
eISSN - 1728-7731
pISSN - 1726-4901
DOI - 10.1097/jcma.0000000000000775
Subject(s) - medicine , saxagliptin , sitagliptin , rosiglitazone , linagliptin , metformin , repaglinide , pharmacology , dapagliflozin , type 2 diabetes , alogliptin , nateglinide , glimepiride , vildagliptin , exenatide , pioglitazone , type 2 diabetes mellitus , liraglutide , dipeptidyl peptidase 4 , insulin , diabetes mellitus , endocrinology